The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 18, 2012
Filed:
Jul. 02, 2009
Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184: insecticidal proteins and methods for their use
Kimberly S. Sampson, Durham, NC (US);
Daniel J. Tomso, Bahama, NC (US);
Nadine Carozzi, Raleigh, NC (US);
Tracy Hargiss, Chapel Hill, NC (US);
Michael G. Koziel, Raleigh, NC (US);
Nicholas B. Duck, Apex, NC (US);
Shruti Agarwal, Durham, NC (US);
Brian Mcnulty, Raleigh, NC (US);
Chris Campbell, Cary, NC (US);
Volker Heinrichs, Raleigh, NC (US);
Kimberly S. Sampson, Durham, NC (US);
Daniel J. Tomso, Bahama, NC (US);
Nadine Carozzi, Raleigh, NC (US);
Tracy Hargiss, Chapel Hill, NC (US);
Michael G. Koziel, Raleigh, NC (US);
Nicholas B. Duck, Apex, NC (US);
Shruti Agarwal, Durham, NC (US);
Brian McNulty, Raleigh, NC (US);
Chris Campbell, Cary, NC (US);
Volker Heinrichs, Raleigh, NC (US);
Athenix Corporation, Morrisville, NC (US);
Abstract
Compositions and methods for conferring insecticidal activity to host cells are provided. Compositions comprising a coding sequence for a delta-endotoxin polypeptide are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in host cells. Compositions also comprise transformed host cells. In particular, isolated delta-endotoxin nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed, and antibodies specifically binding to those amino acid sequences. In particular, the present invention provides for isolated nucleic acid molecules comprising nucleotide sequences encoding the amino acid sequence shown in SEQ ID NO:4, 5, 6, 13, or 14, or the nucleotide sequence set forth in SEQ ID NO:1, 2, 3, 11, or 12, as well as variants and fragments thereof.